Business Development Development Generic Pharmaceutical Life Science 
Pharmaceutical Technology
DECEMBER 22, 2022
The company has partnered with life sciences-focused investors Sixth Street and Royalty Pharma with an aim to bring substantial non-dilutive, low-cost capital to boost innovation and growth. What all the ranked entities have in common is the demonstration of new concepts not just within their own business but in the sector as a whole.
XTalks
AUGUST 2, 2023
is a global pharmaceutical company, working across both developed and emerging markets. They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through business development activities.
Expert insights. Personalized for you.
130 
Let's personalize your content